You might also be interested by
Posters
Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)
March 3, 2026
More infoPosters
Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity
March 3, 2026
More infoWeb News
CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI
March 3, 2026
More infoNews
Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement
February 3, 2026
More info